Cumberland Pharmaceuticals (CPIX) Net Income towards Common Stockholders Growth (1y) (2011 - 2026)
Cumberland Pharmaceuticals (CPIX) Net Income towards Common Stockholders Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 68.18% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | -0.17% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -388.62% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | -14.68% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 105.80% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 2,405.06% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -14.93% |
| 10 | Cumberland Pharmaceuticals | 106.37 Mn | 95.36 Mn | 7.20 Mn | -351.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -351.64% |
| Dec 31, 2025 | 25.57% |
| Sep 30, 2025 | -26.81% |
| Jun 30, 2025 | 33.32% |
| Mar 31, 2025 | 165.61% |
| Dec 31, 2024 | 69.82% |
| Sep 30, 2024 | -44.56% |
| Jun 30, 2024 | -227.89% |
| Mar 31, 2024 | -1,204.25% |
| Dec 31, 2021 | -42.28% |
| Sep 30, 2021 | -36.14% |
| Jun 30, 2021 | -32.47% |
| Mar 31, 2021 | -39.46% |
| Dec 31, 2020 | -63.62% |
| Sep 30, 2020 | -42.35% |
| Jun 30, 2020 | -4.29% |
| Mar 31, 2020 | -28.67% |
| Dec 31, 2019 | 139.82% |
| Sep 30, 2019 | 181.09% |
| Jun 30, 2019 | 203.52% |